Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2010; Volume 198, Supplement 677
Joint Meeting of the Scandinavian and German Physiological Societies
3/27/2010-3/30/2010
Copenhagen, Denmark


STIMULATION OF NA+/CA2+ EXCHANGERS CONTRIBUTES TO THE IMMUNOSUPPRESSIVE EFFECTS OF GLUCOCORTICOIDS AND 1,25-DIHYDROXYVITAMIN D3 IN DENDRITIC CELLS
Abstract number: O-MON-5-3

SHUMILINA1 E, XUAN1 NT, MATZNER1 N, BHANDARU1 M, LANG1 F

Aims: Dendritic cells (DCs) are antigen-presenting cells that provide a link between innate and adaptive immunity. 1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) and dexamethasone (Dex) are powerful immunosuppressors that strongly affect DC functions. On the other hand, DC functions are controlled by Ca2+ signaling. The present study explored whether 1,25(OH)2D3 and Dex influence cytosolic Ca2+ concentration in DCs. Methods: Whole-cell patch-clamp experiments and measurements of cytosolic Ca2+ concentration by Fura-2 fluorescence were performed and expression of maturation markers by DCs was analyzed by flow cytometry. Results: Here we provide evidence that both hormones upregulate Na+/Ca2+ exchangers in DCs. We further demonstrate that this effect results in reduced increase of cytosolic Ca2+ upon application of lipopolysacharide (LPS, 100 ng/ml), an event known to be critical for DC maturation and function. LPS-induced expression of the costimulatory molecule CD86 was down-regulated by 1,25(OH)2D3 and Dex, an effect significantly blunted by the Na+/Ca2+ exchanger blockers 3',4'-dichlorobenzamyl and KB-R7943. Conclusion: 1,25(OH)2D3 and Dex blunt the LPS-induced increase in cytosolic Ca2+ by stimulation of Na+/Ca2+ exchanger-dependent Ca2+ extrusion. The effect contributes to the signaling underlying the inhibition of DC maturation by these immunosuppressive hormones.

To cite this abstract, please use the following information:
Acta Physiologica 2010; Volume 198, Supplement 677 :O-MON-5-3

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE